ЛИТЕРАТУРА, РЕКОМЕНДОВАННАЯ ДЛЯ ЧТЕНИЯ

Поставить закладку

1. Rautava L, Eskelinen J, Hakkinen U, Lehtonen L, PERFECT Preterm Infant Study Group: 5-year morbidity among very preterm infants in relation to level of hospital care. Arch Pediatr Adolesc Med 2013; 167: 40-46.
2. Roberts D, Dalziel S: Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2006:CD004454.
3. Sotiriadis A, Makrydimas G, PapatheodorouS, Ioannidis JP: Corticosteroids for preventingneonatal respiratory morbidity after elective caesarean section at term. Cochrane Database Syst Rev 2009:CD006614.
4. Kenyon S, Boulvain M, Neilson JP: Antibiotics for preterm rupture of membranes. Cochrane Database Syst Rev 2010:CD001058.
5. Doyle LW, Crowther CA, Middleton P, Marret S, Rouse D: Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev 2009:CD004661
6. Rode L, Langhoff-Roos J, Andersson C, Dinesen J, Hammerum MS, Mohapeloa H, Tabor A: Systematic review of progesterone for the prevention of preterm birth in singleton pregnancies. Acta Obstet Gynecol Scand 2009; 88 1180-1189.
7. McCall EM, Alderdice F, Halliday HL, Jenkins JG, Vohra S: Interventions to prevent hypothermia at birth in preterm and/or low birthweight infants. Cochrane Database Syst Rev 2010:CD004210.
8. Committee on Obstetric Practice, American College of Obstetricians and Gynecologists: Committee Opinion No. 543. Timing of umbilical cord clamping after birth. Obstet Gynecol 2012; 120: 1522-1526.
9. Rabe H, Diaz-Rossello JL, Duley L, Dowswell T: Effect of timing of umbilical cord clamping and other strategies to influence placental transfusion at preterm birth on maternal and infant outcomes. Cochrane Database Syst Rev 2012:CD003248.
10. https://www.anzctr.org.au/Trial/Registration/ Trial Review. aspx?id=335752
11. Lista G, Castoldi F, Cavigioli F, Bianchi S, Fontana P: Alveolar recruitment in the delivery room. J Matern Fetal Neonatal Med 2012; (suppl 1):39-40.
12. Методическое письмо Минздрава России «Первичная и реанимационная помощь новорожденным детям» от 21 апреля 2010 г. N 15-4/10/2-3204.
13. European Consensus Guidelines on the Management of Neonatal Respiratory Distress Syndrome in Preterm Infants - 2013 Update Neonatology 2013; 103:353-36 David G.
14. Sweeta Virgilio Carniellic Gorm Greisend Mikko Hallmane Eren Ozekf Richard Plavkag Ola Saugstadh Umberto Simeonii Christian P. Speerj Maximo Ventok Henry L. HallidaybSoll RF: Prophylactic natural surfactant extract for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2000:CD000511.
15. Manual of Neonatal Respiratory Care Third edition Steven Donn Sunil Sinha 2012
16. Soll R, Ozek E: Prophylactic protein free synthetic surfactant for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2010:CD001079.
17. Verlato G, Cogo PE, Benetti E, Gomirato S, Gucciardi A, Carnielli VP: Kinetics of surfacetant in respiratory diseases of the newborn infant. J Matern Fetal Neonatal Med 2004; 16(suppl 2):21-24
18. Cogo PE, Facco M, Simonato M, Verlato G, Rondina C, Baritussio A, Toffolo GM, Carni- elli VP: Dosing of porcine surfactant: effect on kinetics and gas exchange in respiratory distress syndrome. Pediatrics 2009; 124:e950- e957.
19. Singh N, Hawley KL, Viswanathan K: Efficacy of porcine versus bovine surfactants for pre- term newborns with respiratory distress syn- drome: systematic review and meta-analysis. Pediatrics 2011; 128:e1588-e1595.
20. Soll RF, Morley CJ: Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2001:CD000510.
21. Sandri F, Plavka R, Ancora G, Simeoni U, Stranak Z, Martinelli S, Mosca F, Nona J, Thomson M, Verder H, Fabbri L, Halliday HL, CURPAP Study Group: Prophylactic or early selective surfactant combined with nCPAP in very preterm infants. Pediatrics 2010; 125:e1402- e1409.
22. Rojas-Reyes MX, Morley CJ, Soll R: Prophylactic versus selective use of surfactant in pre- venting morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2012:CD000510.
23. Rich W, Finer NN, Gantz MG, Newman NS, Hensman AM, Hale EC, Auten KJ, Schibler K, Faix RG, Laptook AR, Yoder BA, Das A, Shankaran S, SUPPORT and Generic Database Subcommittees of the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network: Enrollment of extremely low birth weight infants in a clinical research study may not be representative. Pediatrics 2012;129: 480-484.
24. Prof Wolfgang Gopel, Angela Kribs, Andreas Ziegler Reinhard Laux, Thomas Hoehn Christian Wieg, Jens Siegel, Stefan Avenarius, Axel von der Wense, Matthias Vochem, MDb MDa, Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preterm infants (AMV): an open-label, randomised, controlled trial. THE LANCET Volume 378, Issue 9803, 5-11 November 2011, Pages 1627-1634
25. Egbert Herting Less Invasive Surfactant Administration (LISA) — Ways to deliver surfactant in spontaneously breathing infants. Early Human Development Volume 89, Issue 11, November 2013, Pages 875-880 63
26. Gortner L, Pohlandt F, Bartmann P, Bernsau U, Porz F, Hellwege HH, Seitz RC, Hieronimi G, Kuhls E, Jorch G, et al. High-dose versus low-dose bovine surfactant treatment in very premature infants. Acta Paediatr. 1994 Feb;83(2):135-41
27. А.Г. Антонов, О.В. Ионов, О.А. Борисевич, Д.С. Крючко, А.А. Ленюшкина Современная респираторная терапия у недоношенных новорожденных в критическом состоянии Педиатрия 2011, №1 12-14
28. Stevens TP, Harrington EW, Blennow M, Soll RF: Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome. Cochrane Database Syst Rev 2007:CD003063.
29. Kattwinkel J, Perlman JM, Aziz K, Colby C, Fairchild K, Gallagher J, et al: Neonatal resus- citation: 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Pediatrics 2010; 126:e1400-e1413.
30. Gommers D., Veen A. et al. Comparison of eight different surfactant preparations on improvement of blood gases in lung-lavaged rats // J Appl Cardiopulmonary pathophysiology 1998; 4: 95-102.
31. Espinosa F.F., Kamm R.D. Bolus Dispersal Through the Lungs in Surfactant Replacement Therapy // J Appl Physiol 1999; 86: 39.
32. Hoekstra R.E., Jackson J.C., Myers T.F. et al. Improved Neonatal Survival Following Multiple Doses of Bovine Surfactant in Very Premature Neonates at Risk for Respiratory Distress Syndrome // Pediatrics 1991; 88; 10;
33. Liechty E.A., Donovan E., Purohit D. et al. Reduction of Neonatal Mortality after Multiple Doses of Bovine Surfactant in Low Birth Weight Neonates with Respiratory Distress Syndrome // Pediatrics 1991; 88; 19;
34. Gunkel et al. Two-year follow-up of infants treated for neonatal respiratory distress syndrome with bovine surfactant // The Journal of Pediatrics 1994, 124 (6);
35. Horbar J.D., Soil R.F., Schachinger H. et al. A European multicenter randomized controlled trial of single dose surfactant therapy for idiopathic respiratory distress syndrome // Eur J Pediatr 1990, 149: 416-423
36. C. Malloy et al. A randomized trial comparing beractant and poractant treatment in neonatal respiratory distress syndrome // Acta Padiatrica, 2005; 94: 779-784;
37. A. Fujii et al. Poractant alfa and beractant treatment of very premature infants with respiratory distress syndrome // Journal of Perinatology 30, 665-670;
38. Trembath A., Hornik C.P., Clark R. et al. Comparative Effectiveness of 3 Surfactant Preparations in Premature Infants // J Pediatr 2013; 163: 955-960;
39. Paul S., Rao S., Kohan R. et al. Poractant alfa versus beractant for respiratory distress syndrome in preterm infants: A retrospective cohort study // J Paediatr Child Health 2013; 49 (10): 839-44].
40. Sweet D., Carnielli V., Greisen G., et al. European Consensus Guidelines on the Management of Neonatal Respiratory Distress Syndrome in Preterm Infants - 2013 Update // Neonatology 2013; 103: 353-368;
41. Sakonidou S., Dhaliwal J.The Management of Neonatal Respiratory Distress Syndrome in Preterm Infants (European Consensus Guidelines - 2013 Update) // Arch Dis Child Educ Pract Ed 2015; 0:1-3.
42. Polin R., Carlo W., and Committee on fetus and newborn. Surfactant Replacement Therapy for Preterm and Term Neonates With Respiratory Distress // Pediatrics 2014; 133: 156 - 163.

Для продолжения работы требуется Регистрация

Предыдущая страница

Следующая страница